Replies to post #3003 on Windtree Therapeutics Inc (WINT)

[H2R]

Top-line AEROSURF Phase 2b On Track for July 2017-

It's been harrowing, but one major catalyst is coming up. If the data is poor, I don't see how long the company will survive. If the data is positive, it may be able to raise funds / (partnership??) and continue on a pivotal trial.

Life ain't dull in the biotech world, that's for sure!